erythropoietin
美 
英 [?r?θr?'p???t?n]
- n.紅細胞生成素；〔生化〕促紅細胞；促紅素
- 網絡紅血球生成素；促紅細胞生成素；紅血球生長激素
英漢解釋
英英解釋
例句
Because we've learned about that biology we've been able to make erythropoietin outside the body and use it as a drug.
由于我們已經知道了這種生物學機制，因此我們能體外制造促紅細胞生成素，并作為藥品應用
BACKGROUND: Recombinant human erythropoietin is commonly used for treatment of anaemia.
背景：重組體人紅細胞生成素通常用于治療貧血。
The stimulating effect of recombinant-erythropoietin (EPO-A) on erythropoiesis has raised interest in its administration as an alternative.
因而重組促紅細胞生成素對紅細胞生成的刺激作用作為一種替代方法引起了人們的關注。
Millions of cancer and kidney disease patients take ESAs, man-made versions of a human hormone called erythropoietin.
上百萬癌癥和腎臟疾病患者服用ESA，這種人造荷爾蒙能提高紅血球數量。
However, the role of erythropoietin and its underlying mechanism in macrophage foam cell formation are poorly understood.
但是，在巨噬細胞形成泡沫細胞過程中，促紅細胞生成素的作用及機制并不清楚。
Background: Erythropoietin is a naturally occurring hormone with multiple effects on a number of different cell types.
背景資料：促紅細胞生成素是一種天然存在的激素，對能對各種不同的細胞發揮多種作用。
Continuous erythropoietin receptor activator(CERA) is a third-generation erythropoiesis-stimulating agents(ESA).
持續型EPO受體激活劑（CERA）是新出現的一種第三代紅細胞生成刺激劑（ESA）。
Ortho Biotech, for example, recently changed one of the chemicals added to its erythropoietin alpha medicine as a stabilizer.
舉例來說，美國奧多生物科技公司最近換了加在紅血球生成素里頭的一種安定劑。更詳細。
Authors analysed concentration of erythropoietin (EPO) in fetal blood from pregnancies complicated by serologic conflict.
作者分析了濃度的紅細胞生成素（EPO）在胎血從懷孕復雜血清沖突。
through the secretion of erythropoietin production, and promote bone marrow hematopoiesis.
通過分泌促紅細胞生產素，促進骨髓造血。
hemoglobin levels in the US end-stage renal disease population have steadily increased since recombinant erythropoietin became available.
自從重組促紅細胞生成素應用以來，美國終末期腎臟疾病患者的血紅蛋白水平穩步上升。
Objective: To approach clinical application of erythropoietin in management of anemia in malignancy hematologic disease.
目的：探討促紅細胞生成素在治療惡性血液病患者貧血中的臨床應用。
The benefits of recombinant human erythropoietin treatment in this patient population have been well shown.
的好處，重組人紅細胞生成素治療的病人以及人口已顯示。
ConclusionAnemia is not related with iron metabolism in vivo in patients who has urinemia, the main reason is lacking of erythropoietin.
結論：尿毒癥患者貧血的發生與體內鐵代謝無關，其貧血的主要原因在于促紅細胞生成素缺乏。
This invention relates to a kind of protein that possesses erythropoietin activity and its preparation.
本發明涉及一種具有促紅細胞生長因子活性的蛋白質及其制備方法。
RESULTS Recombinant human erythropoietin injection in 150-fold dilution had no interference to the bacterial endotoxin test.
結果重組人紅細胞生成素注射液稀釋150倍對細菌內毒素檢查法無干擾。
Recent data have suggested neuroprotective and perhaps even neurotrophic roles for erythropoietin.
最新資料認為促紅細胞生成素在神經保護和神經再生方面亦發揮作用。
Effects of erythropoietin or nitric oxide synthesis inhibitor on hyperdynamic circulatory state in cirrhotic rats.
促紅細胞生成素與一氧化氮合酶抑制劑對肝硬化大鼠高動力循環狀態的影響。
Released kidney lysosomal enzymes may be concerned in the generation of erythropoietin.
釋放的腎臟溶酶體的酶可能與產生促紅細胞生成素有關。
Erythropoietin, the principal regulator of erythroids progenitor cells, is widely used to treat anemia caused by many diseases.
促紅細胞生成素是一種造血因子，臨床中廣泛應用于治療各種原因造成的貧血。
Apart from the red cell surface, erythropoietin 's receptor (Epo-R) is also expressed in a large variety of normal tissues.
促紅細胞生成素的受體除分布在紅血球表面外，也在大批正常組織表達。
Objective: To investigate in vitro release characteristics of collagen double layer minipellet of erythropoietin(EPO).
目的：對紅細胞生成素膠原蛋白雙層微條的體外釋放特性進行研究。
Erythropoietin has been shown to shorten survival in cancer patients under certain circumstances.
促紅細胞生成素已被證明縮短癌癥患者的存活率在某些情況下。
The IOC Medical Commission has approved a test to detect the use of the banned synthetic hormone erythropoietin, or EPO.
國際奧委會藥物委員會已經通過了一項測試來檢測違禁使用合成激素紅細胞生成素（簡稱EPO）的情況。
The invention discloses a blood brain barrier penetrable erythropoietin (EPO) which belongs to the field of biological pharmacy.
本發明公開了一種血腦屏障穿透性促紅細胞生成素，屬于生物制藥領域。
In addition, the kidney also has control of blood pressure, stimulating erythropoietin, and maintain an important role in bone health.
此外，腎臟還具有控制血壓、刺激紅細胞生成、保持骨骼健康等重要作用。
The most frequent causes of PTA were erythropoietin (EPO) and iron deficiency.
導致PTA最常見的原因是紅細胞生成素（EPO）和缺鐵。
During latest years, recombinant human erythropoietin (rHuEPO) has received attention to the influence of human immune system.
近年來，重組人促紅細胞生成素對人體免疫系統的影響開始受到重視。
Hepatology Digest: What about in China and the use of erythropoietin?
國際肝病：在中國促紅細胞生成素的應用如何？
Clinic study of erythropoietin therapy and autohemotherapy in the child cardiac operation
小兒心臟手術促紅細胞生成素治療和術前自體獻血的臨床研究
New Preparation of Recombinant Human Erythropoietin and Study of Its Stability
重組人紅細胞生成素新制劑及其穩定性研究
Clinical Study of Recombinant Human Erythropoietin in Preventing and Treating Anemia of Prematurity in Very Low Birth Weight Infants
重組人類促紅細胞生成素防治極低出生體重兒貧血的臨床研究
Clinical comparison study of recombinant human erythropoietin in preventing anemia of very-low-birth-weight infants
重組人類促紅細胞生成素預防極低出生體重兒貧血的研究
Comparing and Analysis of the Quality Standards of Recombinant Human Erythropoietin Both in European Pharmacopoeia and Chinese Pharmacopoeia
重組人促紅細胞生成素在國內外藥典中質量標準不同點的對比分析
Clinical study of mRNA expression of erythropoietin receptor before and after renal transplantation
腎移植前后骨髓紅細胞生成素受體基因表達的臨床研究
An experimental study of recombinant human erythropoietin on the treatment of acute myocardial infarction in rats
重組人紅細胞生成素對心肌梗死治療作用的實驗研究
Study of the relationship between serum erythropoietin and carcinous anemia
癌性貧血與血清促紅細胞生成素關系研究
Clinical study of recombinant human erythropoietin used in 21 perioperative patients
圍手術期應用重組人促紅細胞生成素21例的經驗
Study of Correlation between Serum Erythropoietin and Hemoglobin in Anemic Patients of Chronic Renal Failure
慢性腎衰患者促紅細胞生成素與血紅蛋白的相關性研究
An experimental study of recombinant human erythropoietin in the treatment of acute myocardial infarction in rats
重組人紅細胞生成素對大鼠心肌梗死的治療作用
